Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Aprea Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 22 | +1 |
| Shares | 1.70M | 58.1K | 2.24M | +606.9K (+37.1%) |
| Value | $1.45M | $49.5K | $1.71M | +$315.5K (+22.6%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Aprea Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vestal Point Capital, LP | 350,000 | $267.0K | 0.01% |
| Scientech Research LLC | 60,281 | $46.0K | 0.04% |
| Vanguard Fiduciary Trust Co | 38,464 | $29.3K | 0.00% |
| Renaissance Technologies LLC | 25,100 | $19.1K | 0.00% |
| Vanguard Capital Management LLC | 19,622 | $15.0K | 0.00% |
| Two Sigma Securities, LLC | 13,500 | $10.3K | 0.00% |
| Susquehanna International Group, LLP | 13,018 | $9.93K | 0.00% |
Sold out (6)
Institutions that held Aprea Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Murchinson Ltd. | 340,139 | $290.1K |
| DRW Securities, LLC | 120,651 | $102.9K |
| Citadel Advisors LLC | 51,041 | $43.5K |
| Jane Street Group, LLC | 46,621 | $39.8K |
| XTX Topco Ltd | 24,304 | $20.7K |
| Bank of America Corp | 3,299 | $2.81K |
Not filed for Q1 2026 yet (1)
Institutions that held Aprea Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 58,086 | $49.5K |